# Lufax Holding Ltd: financial statements, quarterly

LU · NYSE · CIK 1816007 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lu.md) · [Financials](/companies/lu/financials.md) · [Filings](/companies/lu/filings.md) · [Insiders](/companies/lu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lu/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [18.6](/filings/0001193125-21-077780.md) | [18.6](/filings/0001193125-22-135270.md) | [7.3](/filings/0001193125-23-094627.md) | [23.8](/filings/0001193125-24-106025.md) | [26.5](/filings/0001193125-26-053042.md) | [29.6](/filings/0001193125-26-053042.md) | [18.6](/filings/0001193125-26-053042.md) | [11.8](/filings/0001193125-26-053042.md) |
| Total assets | $bn | not reported | not reported | [150](/filings/0001193125-21-077780.md) | [249](/filings/0001193125-22-135270.md) | [360](/filings/0001193125-23-094627.md) | [351](/filings/0001193125-26-053042.md) | [234](/filings/0001193125-26-053042.md) | [204](/filings/0001193125-26-053042.md) |
| Total liabilities | $bn | not reported | not reported | [101](/filings/0001193125-21-077780.md) | [166](/filings/0001193125-22-135270.md) | [266](/filings/0001193125-23-094627.md) | [257](/filings/0001193125-26-053042.md) | [142](/filings/0001193125-26-053042.md) | [120](/filings/0001193125-26-053042.md) |
| Shareholders' equity | $bn | [21.2](/filings/0001193125-21-077780.md) | [34.9](/filings/0001193125-22-135270.md) | [48.0](/filings/0001193125-21-077780.md) | [81.6](/filings/0001193125-22-135270.md) | [93.1](/filings/0001193125-23-094627.md) | [92.1](/filings/0001193125-26-053042.md) | [90.9](/filings/0001193125-26-053042.md) | [81.8](/filings/0001193125-26-053042.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,733,376,334 at 2024-12-31, from the cover of the [20-F filed 2026-02-17](/filings/0001193125-26-053042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.